Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color

Eligibility Criteria

• * Healthy males and females, ≥ 18 years of age at time of informed consent, seeking treatment for acne scarring
• * Subject must voluntarily sign and date an IRB approved informed consent form
• * Subjects with diagnosis of acne scarring recorded over the past 6 months
• * Able to read, understand and voluntarily provide written informed consent.
• * Subject is determined to be healthy, non-smoker
• * Subjects able and willing to comply with the treatment protocol and follow-up schedule and requirements.
• * Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period.
• * Subjects does not have the capacity to consent to the study
• * subject underwent any acne scar treatments in the past 6 months prior to enrollment in the study
• * Subject has active papulopustular or cystic acne within the past 6 months.
• * Any history of keloidal scarring.
• * Any previous surgical procedure in the treatment area in the past 12 months, or major surgery in the last 6 months.
• * History of immunosuppression/immune deficiency disorders (including AIDS and HIV infection), and/or any history of systemic chemotherapy for prior 12 months.
• * History or current use of the following prescription medications:
• * Accutane or other systemic retinoids within the past twelve months
• * Smoking or vaping in the past 12 months.
• * History of photosensitivity and/or connective tissue disease
• * History of hyperlipidemia, diabetes mellitus, hepatitis, or bleeding disorders.
• * History of major depressive disorders or endocrine disorders including but not limited to; hypothyroidism, Hashimoto's thyroiditis, or hyperthyroidism.
• * History of ongoing pregnancy, active breastfeeding, cancer, and epilepsy